June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Visual and Anatomic Outcomes of Diabetic Tractional Retinal Detachment Repair in a County Health System
Author Affiliations & Notes
  • Christina Y Weng
    Retina, Baylor College of Medicine-Cullen Eye Institute, Houston, Texas, United States
    Dept. of Ophthalmology, Ben Taub General Hospital, Houston, Texas, United States
  • Salman A. Rahman
    Baylor College of Medicine, Houston, Texas, United States
  • Beena M. Shah
    Baylor College of Medicine, Houston, Texas, United States
  • Mara A. Rivera
    Baylor College of Medicine, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Christina Weng, Allergan, Inc. (C); Salman Rahman, None; Beena Shah, None; Mara Rivera, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2822. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christina Y Weng, Salman A. Rahman, Beena M. Shah, Mara A. Rivera; Visual and Anatomic Outcomes of Diabetic Tractional Retinal Detachment Repair in a County Health System. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2822.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : To analyze visual and anatomic outcomes of diabetic tractional retinal detachment (DTRD) repairs performed by trainees in a large county hospital.

Methods : Retrospective chart review of patients who underwent primary or recurrent DTRD repair from 2014-2016. Primary outcome was visual acuity (Va); secondary outcomes included complication rates at 6 months postoperatively. Unpaired and paired t-tests were used to identify differences in the means. Statistical significance was defined as p-value <0.05.

Results : 139 patients (average age 49.9 years) were included. Mean preoperative visual acuity (Va) was logMAR 1.59 ± 0.50. The majority of cases were primary repairs (83%) and macula-involving (66%). More than half received previous panretinal photocoagulation (PRP) (63%) and preoperative intravitreal anti-VEGF (54%).

Many patients required silicone oil tamponade (45/139); C3F8 was used in 56 patients, SF6 was used in 12 patients, and 31 patients received air/no tamponade. Fifteen eyes (11%) eyes required a retinectomy. One-third (31%) of phakic eyes received cataract extraction +/- intraocular lens implantation concurrently or in the postoperative period.

Mean overall postoperative Va was logMAR 1.56 ± 0.70 (no significant difference from preoperative Va). The only factor which seemed to affect outcome was preoperative anti-VEGF status; patients who received anti-VEGF had a final Va of logMAR 1.38 ± 0.74 vs. 1.76 ± 0.61 amongst those who had not (p = 0.0016, no difference in preoperative Va between the two groups). No significant difference between pre- and postoperative Va was found in subgroup analyses stratifying patients by macula involvement, primary vs. recurrent repair, retinectomy presence, pseudophakic only, baseline HbA1c, history of PRP, or surgeon experience level. The most common postoperative complications were vitreous hemorrhage (30/139 eyes), redetachment (22), and neovascular glaucoma (7).

Conclusions : Although no significant overall difference in preoperative and postoperative Va was seen in this cohort undergoing DTRD repair, preoperative anti-VEGF correlated with a significant improvement in postoperative Va in a subgroup analysis. Despite a complex level of pathology in this patient population and trainees performing the surgeries, surgical success and complication rates were comparable to reports in the literature.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.